Skip to main content

Table 4 The findings of the included studies in meta-analysis

From: Revolutionizing cancer diagnosis and dose biodistribution: a meta-analysis of [68ga] FAPI- 46 vs. [18f] FDG imaging

Ref

Cancer type

Patient No

Key points

[73]

Bone/soft-tissue sarcomas

57

Assessing 68Ga-FAPI uptake and FAP expression, detection rate, PPV, and inter-reader reproducibility

[74]

Head and Neck

40

Assessing diagnostic accuracy, standard uptake values (SUVmax, SUVmean), and tumor-to-background ratio (TBR) comparison

[76]

Liver

27

Comparing all diagnostic imaging techniques

[80]

Cervical

7

Investigating nodal staging, and comparing PET imaging findings with histopathology

[81]

Lung

23

Assessing diagnostic accuracy of 68Ga-FAPI- 46 for nodes, visual as well as quantitative analysis